Vidwan-ID : 460951



  • Dr Amit Sharma

  • Associate Professor
  • Amity University, Punjab
Publications 2006 - 2024

Publications

  • 59
    Journal Articles
  • 2
    Book Chapter
  • 20
    Review
  • 3
    Other
  • 4
    Projects
  • 1
  • 15

Citations / H-Index

5909 Citations
31 h-index
677 Citations

Altmetrics

4
5
14
308
3

Google Scholar

Co-author Network


Expertise

Organic Chemistry

Synthesis, Medicinal Chemistry, Chemical Biology, Diagnosis and therapeutics

Personal Information

Dr Amit Sharma

Male
Amity School of Chemical Sciences Amity University, Sector 82 A, IT City Rd, Block D, Sahibzada Ajit Singh Nagar
Mohali, Punjab, India - 140306


Experience

  • Associate Professor

    Amity School of Chemical Sciences

    Amity University, Punjab

  • Ramalingaswami Re-entry Fellow

    Materials Science and Sensor Applications

    CSIR-Central Scientific Instruments Organisation

  • Research Professor

    Chemistry

    Korea University


Qualification

  • PhD

    Guru Nanak Dev University


Honours and Awards

2019

DBT-Ramalingaswami Fellow

DBT, New Delhi

2017

BK21 plus Postdoc Fellowship

Korea university, Soeul

2004

Junior Research fellowship

CSIR, New Delhi

2019

DBT-Ramalingaswami Fellow

DBT, New Delhi

2017

BK21 plus Postdoc Fellowship

Korea university, Soeul

2004

Junior Research fellowship

CSIR, New Delhi

Read Less

Research Projects

FDG PET-CT and Intraoperative Fluorescent-Glucose Imaging duo for Precision Surgical Therapy

Funding Agency : ICMR, New Delhi

MirDOX: A Novel Hybrid Prodrug to CombatResistance Aganist DNA-Damaging Anti-Cancer Therapies

Funding Agency : SERB, New Delhi

Cancer Selective Molecular Theranostic toOvercome Multidrug Resistance (MDR) in Preclinical Models

Funding Agency : SERB, New Delhi

Read More

FDG PET-CT and Intraoperative Fluorescent-Glucose Imaging duo for Precision Surgical Therapy

Funding Agency : ICMR, New Delhi

MirDOX: A Novel Hybrid Prodrug to CombatResistance Aganist DNA-Damaging Anti-Cancer Therapies

Funding Agency : SERB, New Delhi

Cancer Selective Molecular Theranostic toOvercome Multidrug Resistance (MDR) in Preclinical Models

Funding Agency : SERB, New Delhi

Development of Next Generation TherapeuticTools for Diagnosis and Treatment of Cancer

Funding Agency : DBT, New Delhi

Read Less

Patents




Read More







Read Less